https://www.newswire.ca/news-releases/gsk-canada-submits-respiratory-syncytial-virus-rsv-vaccine-candidate-for-regulatory-review-856610570.html
0
0
11/26/22 at 12:10am
Organization
Canada NewsWire
Authors
/CNW/ - GSK has filed a New Drug Submission (NDS) to Health Canada for its respiratory syncytial virus (RSV) older adult vaccine candidate. If approved, GSK's...
Create an account
or login to join the discussion